Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Journal of Neuroscience Methods
|
December 28, 2007
Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies
Thomas A Lanz, Joel B Schachter
Journal of Neuroscience Methods
|
May 9, 2006
Demonstration of a common artifact in immunosorbent assays of brain extracts: development of a solid-phase extraction protocol to enable measurement of amyloid-beta from wild-type rodent brain
Thomas A Lanz, Joel B Schachter
The Journal of Pharmacology and Experimental Therapeutics
|
September 2, 2004
Lack of specific amyloid-beta(1-42) suppression by nonsteroidal anti-inflammatory drugs in young, plaque-free Tg2576 mice and in guinea pig neuronal cultures
Thomas A Lanz, Gregory J Fici, Kalpana M Merchant
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2004
Studies of Abeta pharmacodynamics in the brain, cerebrospinal fluid, and plasma in young (plaque-free) Tg2576 mice using the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575)
Thomas A Lanz, John D Hosley, Wade J Adams, et al.
Plos One
|
March 19, 2015
STEP levels are unchanged in pre-frontal cortex and associative striatum in post-mortem human brain samples from subjects with schizophrenia, bipolar disorder and major depressive disorder
Thomas A Lanz, J Julie Joshi, Veronica Reinhart, et al.
Molecular Therapy. Methods & Clinical Development
|
November 7, 2024
Comparison and cross-validation of long-read and short-read target-enrichment sequencing methods to assess AAV vector integration into host genome
Mark Sheehan, Steven W Kumpf, Jessie Qian, et al.
Neurobiology of Disease
|
March 23, 2015
Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder
Veronica Reinhart, Susan E Bove, Dmitri Volfson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 11, 2003
The gamma-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces A beta levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice
Thomas A Lanz, Carol S Himes, Giovanni Pallante, et al.
BMC Genomics
|
January 22, 2020
3'Pool-seq: an optimized cost-efficient and scalable method of whole-transcriptome gene expression profiling
Gabriel Sholder, Thomas A Lanz, Robert Moccia, et al.
Toxicology and Applied Pharmacology
|
June 9, 2023
Thymic lymphoma detection in RORγ knockout mice using 5-hydroxymethylcytosine profiling of circulating cell-free DNA
Kelly A Fader, Mark M Gosink, Shuhua Xia, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Journal of Neuroscience Methods
|
December 28, 2007
Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Abeta quantification following passive immunization with Abeta antibodies
Thomas A Lanz, Joel B Schachter
Journal of Neuroscience Methods
|
May 9, 2006
Demonstration of a common artifact in immunosorbent assays of brain extracts: development of a solid-phase extraction protocol to enable measurement of amyloid-beta from wild-type rodent brain
Thomas A Lanz, Joel B Schachter
The Journal of Pharmacology and Experimental Therapeutics
|
September 2, 2004
Lack of specific amyloid-beta(1-42) suppression by nonsteroidal anti-inflammatory drugs in young, plaque-free Tg2576 mice and in guinea pig neuronal cultures
Thomas A Lanz, Gregory J Fici, Kalpana M Merchant
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2004
Studies of Abeta pharmacodynamics in the brain, cerebrospinal fluid, and plasma in young (plaque-free) Tg2576 mice using the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY-411575)
Thomas A Lanz, John D Hosley, Wade J Adams, et al.
Plos One
|
March 19, 2015
STEP levels are unchanged in pre-frontal cortex and associative striatum in post-mortem human brain samples from subjects with schizophrenia, bipolar disorder and major depressive disorder
Thomas A Lanz, J Julie Joshi, Veronica Reinhart, et al.
Molecular Therapy. Methods & Clinical Development
|
November 7, 2024
Comparison and cross-validation of long-read and short-read target-enrichment sequencing methods to assess AAV vector integration into host genome
Mark Sheehan, Steven W Kumpf, Jessie Qian, et al.
Neurobiology of Disease
|
March 23, 2015
Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder
Veronica Reinhart, Susan E Bove, Dmitri Volfson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 11, 2003
The gamma-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces A beta levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice
Thomas A Lanz, Carol S Himes, Giovanni Pallante, et al.
BMC Genomics
|
January 22, 2020
3'Pool-seq: an optimized cost-efficient and scalable method of whole-transcriptome gene expression profiling
Gabriel Sholder, Thomas A Lanz, Robert Moccia, et al.
Toxicology and Applied Pharmacology
|
June 9, 2023
Thymic lymphoma detection in RORγ knockout mice using 5-hydroxymethylcytosine profiling of circulating cell-free DNA
Kelly A Fader, Mark M Gosink, Shuhua Xia, et al.
Page
of 5